• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

ImmunoGen - Articles and news items

ovarian cancer

ImmunoGen and Merck collaborate for ovarian cancer trial

Industry news / 5 February 2016 / Victoria White

The companies are to are to assess ImmunoGen’s mirvetuximab soravtansine in combination with Merck’s Keytruda (pembrolizumab) in FRα-positive ovarian cancer…


Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +